STINA RUDDELL: Open Payments
NPI 1770876302 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 100 payments from 21 companies in 2025. Trend: 2023 $1,107 · 2024 $1,464 · 2025 $2,173
Food & beverage: $1,866Education: $307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $372 |
| Janssen Biotech, Inc. | 3 | $266 |
| Regeneron Healthcare Solutions, Inc. | 8 | $253 |
| UCB, Inc. | 9 | $239 |
| PFIZER INC. | 23 | $225 |
| Amgen Inc. | 12 | $190 |
| LEO Pharma Inc. | 4 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Lilly USA, LLC | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, OTEZLA, RINVOQ, CIBINQO, TALTZ.
Industry payments across GA — which companies pay providers there.
